Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noé Seija

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Trends in Immunology|May 22, 2020
AID in Antibody Diversification: There and Back AgainYuqing Feng, Noé Seija, Javier M Di Noia, et al.
Frontiers in Immunology|March 26, 2024
B-cell intrinsic regulation of antibody mediated immunity by histone H2A deubiquitinase BAP1Yue Liang, HanChen Wang, Noé Seija, et al.
Blood|March 1, 2019
Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemiaPablo Elías Morande, Mariela Sivina, Angimar Uriepero, et al.
Nature Communications|January 12, 2026
DOT1L activity limits transcription elongation velocity and favors RNAPII pausing to facilitate mutagenesis by AIDPoorani Ganesh Subramani, Noé Seija, Jana Ridani, et al.
Science Advances|August 24, 2022
AFF3, a susceptibility factor for autoimmune diseases, is a molecular facilitator of immunoglobulin class switch recombinationShin-Ichi Tsukumo, Poorani Ganesh Subramani, Noé Seija, et al.
Cancer Immunology, Immunotherapy : CII|February 15, 2020
Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemiaDenise Risnik, Ana Colado, Enrique Podaza, et al.
Blood|June 10, 2017
S100-A9 protein in exosomes from chronic lymphocytic leukemia cells promotes NF-κB activity during disease progressionDaniel Prieto, Natalia Sotelo, Noé Seija, et al.
British Journal of Haematology|June 29, 2018
LPL protein in Chronic Lymphocytic Leukaemia have different origins in Mutated and Unmutated patients. Advances for a new prognostic marker in CLLDaniel Prieto, Noé Seija, Angimar Uriepero, et al.
Blood|July 22, 2021
AID overexpression leads to aggressive murine CLL and nonimmunoglobulin mutations that mirror human neoplasmsPablo Elías Morande, Xiao-Jie Yan, Julieta Sepulveda, et al.
Nature|November 25, 2021
FAM72A antagonizes UNG2 to promote mutagenic repair during antibody maturationYuqing Feng, Conglei Li, Jessica A Stewart, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Trends in Immunology|May 22, 2020
AID in Antibody Diversification: There and Back AgainYuqing Feng, Noé Seija, Javier M Di Noia, et al.
Frontiers in Immunology|March 26, 2024
B-cell intrinsic regulation of antibody mediated immunity by histone H2A deubiquitinase BAP1Yue Liang, HanChen Wang, Noé Seija, et al.
Blood|March 1, 2019
Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemiaPablo Elías Morande, Mariela Sivina, Angimar Uriepero, et al.
Nature Communications|January 12, 2026
DOT1L activity limits transcription elongation velocity and favors RNAPII pausing to facilitate mutagenesis by AIDPoorani Ganesh Subramani, Noé Seija, Jana Ridani, et al.
Science Advances|August 24, 2022
AFF3, a susceptibility factor for autoimmune diseases, is a molecular facilitator of immunoglobulin class switch recombinationShin-Ichi Tsukumo, Poorani Ganesh Subramani, Noé Seija, et al.
Cancer Immunology, Immunotherapy : CII|February 15, 2020
Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemiaDenise Risnik, Ana Colado, Enrique Podaza, et al.
Blood|June 10, 2017
S100-A9 protein in exosomes from chronic lymphocytic leukemia cells promotes NF-κB activity during disease progressionDaniel Prieto, Natalia Sotelo, Noé Seija, et al.
British Journal of Haematology|June 29, 2018
LPL protein in Chronic Lymphocytic Leukaemia have different origins in Mutated and Unmutated patients. Advances for a new prognostic marker in CLLDaniel Prieto, Noé Seija, Angimar Uriepero, et al.
Blood|July 22, 2021
AID overexpression leads to aggressive murine CLL and nonimmunoglobulin mutations that mirror human neoplasmsPablo Elías Morande, Xiao-Jie Yan, Julieta Sepulveda, et al.
Nature|November 25, 2021
FAM72A antagonizes UNG2 to promote mutagenic repair during antibody maturationYuqing Feng, Conglei Li, Jessica A Stewart, et al.
Pageof 1